Mitchell Dean J
- SEC CIK
- 0001199297
No open-market purchases or sales filed in the past year.
Current role at each company
- TBPH Theravance Biopharma, Inc.Directoras of Sep 24, 2026
- PRAX Praxis Precision Medicines, Inc.Directoras of Jun 12, 2026
- KNTE Kinnate Biopharma Inc.Directoras of Apr 5, 2024
- PGEN Precigen, Inc.Directoras of Mar 18, 2024
- IMGN ImmunoGen, Inc.Directoras of Feb 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mitchell Dean J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PGEN Precigen, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 (view filing) | Sep 22 | 3 days | Mitchell Dean JDirector | PPurchase | +25.0K | $1.41 | +$35.3K | +7.5%356.8K after |
PRAX Praxis Precision Medicines, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 (view filing) | Mar 24 | 3 days | Mitchell Dean JDirector | PPurchase | +50.0K | $0.84 | +$42.0K | +200.0%75.0K after | |
| Jun 9, 2022 (view filing) | Jun 8 | 1 day | Mitchell Dean JDirector | PPurchase | +25.0K | $1.81 | +$45.3K | New position25.0K after |